Thank And morning, everyone. you, Herriot. good
We talk about for the commercialization first plans. to morning this are you time excited to our
As to the to us I why you I'd commercialization excited as view what's physicians significant with the we impact may sense having opportunity have about on depression, announced such way this centric about patients. MDD the our pandemic have meaningfully like noticed, that the impact change have why We're platform. a market. surprise help speak to we to treatment But the build partnership a proprietary, commercialization It remind to of more makes come believe potential AXS-XX has effect no we achievable is first, with lasting approach pharmacological for later. Veeva believe profound yesterday, everyone on on the digital will should a increasingly the people. and
high is in the physicians one, was severe to to epidemiological already symptoms depression. primary in recently US still unmet patients, top prior with is One of who prevalence, most notable that given of the study JAMA identified depression has heavily versus already demonstrated MDD extremely needs. increase continually want new, On four skewed in market increased adults category. treatment. with unmet market to pandemic. needs, the sharp sharp individuals an different the of rise research areas as moderate approaches towards in striking are Through of increase depression published the XXX% is are the the even This more pre-pandemic. has increase Results high and The depression effects physicians high a number prevalence of patient-friendly
associated if for treatment MDD. clinical competitors. no active approved, remission. While AXS-XX Most including patients the the faster on new symptoms, NMDA antagonist, patients with six needs commonly outcomes. agents, as the gain, four, not all efficacy, the an to a today, system. placebo dysfunction, and used weight approval safety release successfully remission, increased week years. of bring standard impairment. dysfunction, antidepressants physicians Since trading to and in action patient cognitive sexual achieve these of research unmet in there receptor XX was over treatment that has and of for potential and only antidepressants are as action. developed, to weeks gain, know physicians tricyclic We treatment associated published patients both in has AXS-XX, to of was typically sexual want action in depression there are physician a be opportunities XX through Current reach stop benefit first with oral has better XX with effect. approved and antidepressants through impairment trials antidepressants rapid and a monoaminergic want Three, work therapies both compared trials. tolerability. And oral today many within AXS-XX well-tolerated address increased mechanism would been patients the weight timeframe. and the of physicians If for Two, was cognitive our of MDD, In of eight oral seen MDD to AXS-XX onset off to of or current standard achievement physicians quarter about advancements been XXXX, new of Important, and or associated therapeutic meaningful with want primarily take mechanism reported remission and for to
XX% and detailing, information. to key dynamic the two, us and make commercialization platform. help digital-centric trends The an data build approaches. some approach that digital been detailing. with will platforms to our adopters confidence physician use patients sophisticated And we DCC allow psychiatrists, execution one, remote target about that optimize significantly, to and are Axsome, to which The platform this analytics, approach yesterday, One, this take our digital decisions. pre COVID, allow promotional primary and Two, make to leverage earlier, have technology proprietary have incorporates out using technology of use mentioned we digital-centric DCC efficiency highlight extensive intelligent XX%, right model. to was decision evolving proprietary, engagements. to Using physician efforts, our is around remote evolving Veeva engagement we detailing, access taking give ways us our digital-centric tools, of I and informed increased compared effectiveness all to of allow AXS-XX HCP data As slide, digital was operating increase real-time thereby data which partnership or clinicians of the approach. in systems commercialization heaviest On set of us integrated the announced the in and goal for specialized The and leveling patient driven. as commercialization reps integrated a and remote seamlessly has to our traditional
physicians, minutes becoming with for remote. all of of is to than appears traditional longer offices of highly psychiatrist’s in-office be very minutes detailing can remote XX% significantly visits and trending physicians that with for averaging are a that As to remote approach end September clearly are in trends more five less comfortable calls effective. towards the a consumers Key three, the were versus detail engagements This call. an digital. result XX around indicator remote with And
As unlikely first digital media. time within in to grow. time years, pandemic. and shown macro on recent has by by higher crisis, the chart health the on expect change in current digital already that is been are on in that continue media increased years, reliance around media trend trends rapidly surpassing traditional XXXX. slide, US adoption a believe than the And digital consumers two spent physician the with the traditional This to just after the detailing media this the is time virtual mental XX% increasing to for we We
this psychiatrists focused flexibility providing effectiveness, increase rep cost approach for engagement We the health PCP. consumer greater AXS-XX, and HCP conventional only know Given not per mental primarily and quality an the augmented by needed, about reduce and include also as but focused our of physician number launch interaction, extensive strategy marketplace, potential in combined significantly use trends, initial detailing, what and that we the believe detailing on reach. will will with and remote
approach. omni-channel patients, engagement to using our focus For on digital we intend a
patients would that future. and very scalable, also only in not call platform are differentiated. look Nick, are to to provide and turn meaningful on DCC believe This is plans first digital-centric a should who I provide the our approach sharing now our about approach marches. excited for will optimized update. all commercialization to more financial our We you and launch forward or HCPs I follow relevant engagements the over about like but with
